🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
The goal of this clinical research study is to compare how 2 different drug...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2014-10-13
Trial ID
NCT02269280
This phase I trial is studying the side effects and best dose of decitabine...
Status
Terminated
Location
Princess Margaret Hospital Phase 2 Consortium
Start Date
2002-09
Trial ID
NCT00049582
Treatments Being Tested
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
Background: Acute myeloid leukemia (AML) is a cancer of the white blood ce...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2016-12-16
Trial ID
NCT02996474
Treatments Being Tested
This phase I trial is studying the side effects and best dose of vorinostat...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00357708
Treatments Being Tested
To compare efficacy and safety between SGI-110 and Treatment Choice in adul...
Status
Completed
Location
Mayo Clinic Cancer Center
Start Date
2015-03-19
Trial ID
NCT02348489
Treatments Being Tested
A prospective open-label phase 2 study will be designed to assess the effic...
Status
Unknown
Location
The University of Hong Kong
Start Date
2021-01-01
Trial ID
NCT04689815
Treatments Being Tested